Skip to main content
TipRanks
Go Ultimate75% OFF

Alexander Lussow Insider Profile

4 Followers

Alexander Lussow, former Sr. VP, Bus. Dev. & Comm. Op. at Novelion Therapeutics, holds 20.00K shares in Novelion Therapeutics (Ticker: NVLNF). Most recently, Alexander Lussow Sold 90,000 shares of Novelion Therapeutics on May 06, 2013 for an estimated value of $706.50K.

Alexander Lussow's Trading History

NVLNF
Novelion Therapeutics
May 06, 2013―Informative Sell706.50K$14.04K
NVLNF
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 06, 2013Informative Sell$706.50K90,000$7.85-39.10%
Dec 28, 2012Informative Sell$1.73M230,000$7.51-37.40%
Dec 13, 2012Uninformative Sell$40.10K5,000$8.02―
Nov 29, 2012Uninformative Sell$39.40K5,000$7.88―
Nov 21, 2012Uninformative Sell$39.05K5,000$7.81―

You May Also Like

Alexander Lussow insider profile FAQ

What is the percentage of profitable transactions made by Alexander Lussow?
The percentage of profitable transactions made by Alexander Lussow is 40%.
What is the average return per transaction made by Alexander Lussow?
The average return per transaction made by Alexander Lussow is 17.30%.
What stocks does Alexander Lussow hold?
Alexander Lussow holds: NVLNF stocks.
What was Alexander Lussow’s latest transaction?
Alexander Lussow’s latest transaction was an Informative Sell of $706.50K.
What was Alexander Lussow's most profitable transaction?
Alexander Lussow’s most profitable transaction was an Informative Buy of NVLNF stock on February 24, 2009. The return on the trade was 174.70%.
What is Alexander Lussow's role in Novelion Therapeutics?
Alexander Lussow's role in Novelion Therapeutics is Sr. VP, Bus. Dev. & Comm. Op..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.